Zhejiang Cheng Yi Pharmaceutical Co., Ltd. (SHA:603811)

SHA:603811 Revenue

Zhejiang Cheng Yi Pharmaceutical had revenue of 180.36M CNY in the quarter ending September 30, 2025, with 9.47% growth. This brings the company's revenue in the last twelve months to 790.86M, up 7.94% year-over-year. In the year 2024, Zhejiang Cheng Yi Pharmaceutical had annual revenue of 714.37M with 6.36% growth.

• Revenue (ttm): 790.86M
• Revenue Growth: +7.94%
• P/S Ratio: 4.68
• Revenue / Employee: 1.24M
• Employees: 637
• Market Cap: 3.70B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	714.37M	42.74M	6.36%
Dec 31, 2023	671.63M	16.65M	2.54%
Dec 31, 2022	654.97M	-38.99M	-5.62%
Dec 31, 2021	693.96M	-64.17M	-8.46%
Dec 31, 2020	758.13M	76.90M	11.29%